Skip to content
Taxonomy
CMTA-STAR Alliance Partner NMD Pharma Announces FDA Orphan Drug Designation for NMD670
NMD Pharma A/S, a CMTA-STAR Alliance Partner, recently announced that Read More
Simply CMT Podcast
The Simply CMT Podcast is presented by the Charcot-Marie-Tooth Association. Read More
CMTA-STAR Alliance Partner NMD Pharma Publishes Transformative Study on Charcot-Marie-Tooth Disease
CMTA-STAR Alliance Partner NMD Pharma A/S has announced the publication Read More
CMTA Announces New Center of Excellence at Virginia Commonwealth University
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
CMTA Announces New Center of Excellence at Duke University Hospital
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
CMTA Announces New Center of Excellence in Kentucky
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Read More
CMTA-STAR Collaboration Celebrates a Decade of CMT Genetic Discovery Through the GENESIS Database
Exciting progress from CMTA’s Strategy To Accelerate Research (STAR) program Read More
Alliance Partner NMD Pharma A/S Launches Phase II SYNAPSE-CMT Trial with First Patient Dosed at CMTA Center of Excellence
The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA-STAR Alliance Partner NMD Pharma Read More
CMTA-INC Strategic Alliance Announces the 2025 Inherited Neuropathy Fellowship
The Charcot-Marie-Tooth Association (CMTA), through its strategic alliance with the Read More
CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types
CMTA strengthens its role as the leading force in comprehensive Read More
